- Home
- IRON vs PLTK Comparison
IRON vs PLTK Comparison
Compare IRON & PLTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- PLTK
- Stock Information
- Founded
- IRON 2017
- PLTK 2010
- Country
- IRON United States
- PLTK Israel
- Employees
- IRON N/A
- PLTK N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- PLTK EDP Services
- Sector
- IRON Health Care
- PLTK Technology
- Exchange
- IRON Nasdaq
- PLTK Nasdaq
- Market Cap
- IRON 2.1B
- PLTK 2.0B
- IPO Year
- IRON N/A
- PLTK 2021
- Fundamental
- Price
- IRON $59.76
- PLTK $4.46
- Analyst Decision
- IRON Strong Buy
- PLTK Buy
- Analyst Count
- IRON 12
- PLTK 7
- Target Price
- IRON $92.08
- PLTK $7.68
- AVG Volume (30 Days)
- IRON 330.3K
- PLTK 1.2M
- Earning Date
- IRON 08-11-2025
- PLTK 08-07-2025
- Dividend Yield
- IRON N/A
- PLTK 8.98%
- EPS Growth
- IRON N/A
- PLTK N/A
- EPS
- IRON N/A
- PLTK 0.37
- Revenue
- IRON N/A
- PLTK $2,604,100,000.00
- Revenue This Year
- IRON N/A
- PLTK $13.33
- Revenue Next Year
- IRON N/A
- PLTK $3.95
- P/E Ratio
- IRON N/A
- PLTK $11.89
- Revenue Growth
- IRON N/A
- PLTK 1.64
- 52 Week Low
- IRON $30.82
- PLTK $3.97
- 52 Week High
- IRON $68.73
- PLTK $8.80
- Technical
- Relative Strength Index (RSI)
- IRON 61.73
- PLTK 39.80
- Support Level
- IRON $58.63
- PLTK $4.58
- Resistance Level
- IRON $61.59
- PLTK $4.93
- Average True Range (ATR)
- IRON 2.15
- PLTK 0.16
- MACD
- IRON -0.14
- PLTK -0.02
- Stochastic Oscillator
- IRON 64.07
- PLTK 16.61
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.